NASDAQ$GNLX

Genelux Corporation · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Headline financials

Total Revenue

$0.00

Previous: $11M-100.0%
EPS (adj)

-$0.20

Previous: $0.54-137.0%
Capital Expenditures

-$277K

Previous: $33K-939.4%
Free Cash Flow

-$3.63M

Previous: -$2.5M-45.2%
Net Income

-$5.35M

Previous: $4.91M-208.9%
Operating Income

-$5.31M

Previous: $6.34M-183.7%
Gross Profit

-$272K

Previous: $10.8M-102.5%
Cash & Equivalents

$29.9M

Previous: $1.37M+2080.2%
Total Assets

$34.1M

No prior period
R&D Expense

$2.82M

No prior period
Stock-Based Comp

$515K

Previous: $1.7M-69.8%

Revenue & EPS history

Genelux · Revenue · Quarterly

$0

Q3 2023-100%vs Q3 2022
Beat estimate in 1 of 1 quarters(100%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 16 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

-4.7%

Avg return

Earnings day

-5.1%

Avg return

5 days after

-0.7%

Avg return

30 days after

31%

5 / 16 earnings

Positive

+4.7%

Q2 2023

Best reaction

-31.4%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-6.9%+12.1%+3.9%
Q3 2025-31.4%-23.7%-40.8%
Q2 2025-6.0%-4.2%+0.9%
Q1 2025+4.5%+0.4%+30.2%
Q4 2024-4.4%-11.5%-10.2%
Q3 2024-16.0%-11.7%-17.1%
Q2 2024+3.4%+1.5%+18.4%
Q1 2024+1.1%-5.5%-39.8%
Q4 2023-18.4%-23.3%-49.0%
Q3 2023-4.8%-16.2%+4.6%
Q3 2022-4.8%-16.2%+4.6%
Q2 2022+4.7%+3.6%-8.6%
Q2 2023+4.7%+3.6%-8.6%
Q4 2022-0.4%+3.4%+33.6%
Q1 2022-0.4%+3.4%+33.6%
Q1 2023-0.4%+3.4%+33.6%
Q4 2021
Q3 2021
Q2 2021
Q1 2021
Q4 2020
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro